• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 康复后 6 个月内 T 细胞表型和反应的改变:一项队列研究。

Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.

机构信息

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, CAS, Wuhan, 430071, China.

University of Chinese Academy of Sciences, Beijing, 100049, China.

出版信息

Virol Sin. 2021 Oct;36(5):859-868. doi: 10.1007/s12250-021-00348-0. Epub 2021 Feb 9.

DOI:10.1007/s12250-021-00348-0
PMID:33560482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7871951/
Abstract

The COVID-19 pandemic, caused by the SARS-CoV-2 infection, is a global health crisis. While many patients have clinically recovered, little is known about long-term alterations in T cell responses of COVID-19 convalescents. In this study, T cell responses in peripheral blood mononuclear cells of a long-time COVID-19 clinically recovered (20-26 weeks) cohort (LCR) were measured via flow cytometry and ELISpot. The T cell responses of LCR were comparatively analyzed against an age and sex matched short-time clinically recovered (4-9 weeks) cohort (SCR) and a healthy donor cohort (HD). All volunteers were recruited from Wuhan Jinyintan Hospital, China. Phenotypic analysis showed that activation marker PD-1 expressing on CD4 T cells of LCR was still significantly lower than that of HD. Functional analysis indicated that frequencies of Tc2, Th2 and Th17 in LCR were comparable to those of HD, but Tc17 was higher than that of HD. In LCR, compared to the HD, there were fewer IFN-γ producing T cells but more IL-2 secreting T cells. In addition, the circulating Tfh cells in LCR were still slightly lower compared to HD, though the subsets composition had recovered. Remarkably, SARS-CoV-2 specific T cell responses in LCR were comparable to that of SCR. Collectively, T cell responses experienced long-term alterations in phenotype and functional potential of LCR cohort. However, after clinical recovery, SARS-CoV-2 specific T cell responses could be sustained at least for six months, which may be helpful in resisting re-infection.

摘要

由 SARS-CoV-2 感染引起的 COVID-19 大流行是一场全球卫生危机。虽然许多患者已经临床康复,但对于 COVID-19 康复者的 T 细胞反应的长期变化知之甚少。在这项研究中,通过流式细胞术和 ELISpot 测量了长时间 COVID-19 临床康复(20-26 周)队列(LCR)外周血单核细胞中的 T 细胞反应。将 LCR 的 T 细胞反应与年龄和性别匹配的短时间临床康复(4-9 周)队列(SCR)和健康供体队列(HD)进行比较分析。所有志愿者均来自中国武汉金银潭医院。表型分析表明,LCR 中 CD4 T 细胞上表达的激活标志物 PD-1 仍明显低于 HD。功能分析表明,LCR 中的 Tc2、Th2 和 Th17 频率与 HD 相当,但 Tc17 高于 HD。在 LCR 中,与 HD 相比,产生 IFN-γ的 T 细胞较少,但分泌 IL-2 的 T 细胞较多。此外,与 HD 相比,LCR 中的循环 Tfh 细胞仍然略低,尽管亚群组成已经恢复。值得注意的是,LCR 中的 SARS-CoV-2 特异性 T 细胞反应与 SCR 相当。总的来说,T 细胞反应在 LCR 队列的表型和功能潜力方面经历了长期的变化。然而,临床康复后,SARS-CoV-2 特异性 T 细胞反应至少可以持续六个月,这可能有助于抵抗再次感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/b7c82369d627/12250_2021_348_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/545b47aa4911/12250_2021_348_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/73150ad661fd/12250_2021_348_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/60f4a9300b40/12250_2021_348_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/ab52c65f9566/12250_2021_348_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/ff683a2a9130/12250_2021_348_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/b7c82369d627/12250_2021_348_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/545b47aa4911/12250_2021_348_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/73150ad661fd/12250_2021_348_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/60f4a9300b40/12250_2021_348_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/ab52c65f9566/12250_2021_348_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/ff683a2a9130/12250_2021_348_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc9/8558115/b7c82369d627/12250_2021_348_Fig6_HTML.jpg

相似文献

1
Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.COVID-19 康复后 6 个月内 T 细胞表型和反应的改变:一项队列研究。
Virol Sin. 2021 Oct;36(5):859-868. doi: 10.1007/s12250-021-00348-0. Epub 2021 Feb 9.
2
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19.从新冠肺炎临床康复的个体中淋巴细胞的广泛表型改变及潜在功能障碍
J Mol Cell Biol. 2021 Jul 6;13(3):197-209. doi: 10.1093/jmcb/mjab014.
3
Detection of IFNγ-Secreting CD4 and CD8 Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2.检测外周血单个核细胞经活 SARS-CoV-2 刺激后 COVID-19 恢复期患者 IFNγ 分泌的 CD4 和 CD8 记忆 T 细胞。
Viruses. 2021 Jul 29;13(8):1490. doi: 10.3390/v13081490.
4
Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.急性和恢复期 COVID-19 患者中异质性 CD8+ T 细胞的成熟和“极化”。
Viruses. 2022 Aug 28;14(9):1906. doi: 10.3390/v14091906.
5
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.在 COVID-19 康复者中鉴定出的 SARS-CoV-2 特异性记忆 T 细胞表位。
Virus Res. 2021 Oct 15;304:198508. doi: 10.1016/j.virusres.2021.198508. Epub 2021 Jul 27.
6
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.COVID-19 康复者感染后 1 年的 SARS-CoV-2 特异性抗体和 T 细胞反应:一项纵向队列研究。
Lancet Microbe. 2022 May;3(5):e348-e356. doi: 10.1016/S2666-5247(22)00036-2. Epub 2022 Mar 23.
7
Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.灭活的 SARS-CoV-2 疫苗可在 HIV 感染者中引发免疫原性和 T 细胞反应。
Int Immunopharmacol. 2022 Jan;102:108383. doi: 10.1016/j.intimp.2021.108383. Epub 2021 Nov 18.
8
Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study.SARS-CoV-2核酸持续阳性的COVID-19患者的T细胞反应特征——一项队列研究
Clin Transl Immunology. 2021 Mar 4;10(3):e1259. doi: 10.1002/cti2.1259. eCollection 2021.
9
Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.COVID-19 康复 2 年后个体对 SARS-CoV-2 的持久性和交叉反应性免疫记忆:一项纵向队列研究。
Lancet Microbe. 2024 Jan;5(1):e24-e33. doi: 10.1016/S2666-5247(23)00255-0. Epub 2023 Dec 1.
10
Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab.奥瑞珠单抗治疗多发性硬化症患者的 SARS-CoV-2 特异性 T 细胞和 B 细胞反应的免疫监测。
Front Immunol. 2023 Sep 20;14:1254128. doi: 10.3389/fimmu.2023.1254128. eCollection 2023.

引用本文的文献

1
IFN-γ decreases PD-1 in T lymphocytes from convalescent COVID-19 patients via the AKT/GSK3β signaling pathway.IFN-γ 通过 AKT/GSK3β 信号通路降低恢复期 COVID-19 患者 T 淋巴细胞中的 PD-1。
Sci Rep. 2024 Feb 29;14(1):5038. doi: 10.1038/s41598-024-55191-6.
2
SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection.在初次感染后 10 个月,康复个体中针对 SARS-CoV-2 的 T 细胞反应明显减弱。
Virol Sin. 2023 Aug;38(4):606-619. doi: 10.1016/j.virs.2023.06.011. Epub 2023 Jul 4.
3
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.

本文引用的文献

1
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19.从新冠肺炎临床康复的个体中淋巴细胞的广泛表型改变及潜在功能障碍
J Mol Cell Biol. 2021 Jul 6;13(3):197-209. doi: 10.1093/jmcb/mjab014.
2
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.
3
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
持续的 SARS-CoV-2 感染、EBV、HHV-6 及其他因素可能导致长新冠中的炎症和自身免疫。
Viruses. 2023 Jan 31;15(2):400. doi: 10.3390/v15020400.
4
Publication trends of research on COVID-19 and host immune response: A bibliometric analysis.COVID-19 与宿主免疫反应研究的发表趋势:文献计量分析。
Front Public Health. 2022 Aug 8;10:939053. doi: 10.3389/fpubh.2022.939053. eCollection 2022.
5
Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview.SARS-CoV-2 感染患者免疫失调反应:全面综述。
Viruses. 2022 May 18;14(5):1082. doi: 10.3390/v14051082.
6
From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases?从 COVID-19 到结节病:这两种疾病有多相似?
Front Immunol. 2022 May 9;13:877303. doi: 10.3389/fimmu.2022.877303. eCollection 2022.
7
Molecular and Cellular Mechanisms of and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection.新型冠状病毒和严重急性呼吸综合征冠状病毒 2 感染的分子和细胞机制-发病机制的意外相似之处及合并感染的预期后果。
Int J Mol Sci. 2022 Feb 17;23(4):2235. doi: 10.3390/ijms23042235.
8
A single dose of COVID-19 vaccine induces a strong T cell and B cell response in healthcare professionals recovered from SARS-CoV-2 infection.一剂 COVID-19 疫苗可诱导 SARS-CoV-2 感染康复的医护人员产生强烈的 T 细胞和 B 细胞反应。
Clin Exp Med. 2023 Jun;23(2):529-537. doi: 10.1007/s10238-022-00801-8. Epub 2022 Feb 21.
9
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection.滤泡辅助 T 细胞在 SARS-CoV-2 感染中的免疫发病机制。
Front Immunol. 2021 Sep 16;12:731100. doi: 10.3389/fimmu.2021.731100. eCollection 2021.
10
The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.T 细胞免疫在 2 型糖尿病患者 COVID-19 严重程度中的作用。
FEBS J. 2021 Sep;288(17):5042-5054. doi: 10.1111/febs.16105. Epub 2021 Jul 31.
无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
4
COVID-19 Makes B Cells Forget, but T Cells Remember.新冠病毒让 B 细胞遗忘,而 T 细胞记住。
Cell. 2020 Oct 1;183(1):13-15. doi: 10.1016/j.cell.2020.09.013. Epub 2020 Sep 4.
5
Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.新型冠状病毒肺炎发病机制中的免疫失同步及其潜在免疫治疗策略。
J Exp Med. 2020 Oct 5;217(10). doi: 10.1084/jem.20200674.
6
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.在 COVID-19 之后,英国康复个体中 SARS-CoV-2 诱导产生的广泛而强大的记忆性 CD4 和 CD8 T 细胞。
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.
7
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.新冠病毒(COVID-19)中 Bcl-6 表达的滤泡辅助性 T 细胞和生发中心的缺失。
Cell. 2020 Oct 1;183(1):143-157.e13. doi: 10.1016/j.cell.2020.08.025. Epub 2020 Aug 19.
8
Not just antibodies: B cells and T cells mediate immunity to COVID-19.不仅是抗体:B 细胞和 T 细胞介导对 COVID-19 的免疫。
Nat Rev Immunol. 2020 Oct;20(10):581-582. doi: 10.1038/s41577-020-00436-4.
9
Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection.无症状SARS-CoV-2感染中T细胞反应的纵向特征
Virol Sin. 2020 Dec;35(6):838-841. doi: 10.1007/s12250-020-00277-4. Epub 2020 Aug 21.
10
Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.外周血单核细胞单细胞测序揭示 COVID-19 和流感患者不同的免疫反应图谱。
Immunity. 2020 Sep 15;53(3):685-696.e3. doi: 10.1016/j.immuni.2020.07.009. Epub 2020 Jul 19.